Amphotec
Cerebral Cryptococcosis, Histoplasmosis, Coccidioidomycosis + 25 more
Treatment
28 FDA approvals
20 Active Studies for Amphotec
Treatment for
Cerebral Cryptococcosis
What is Amphotec
Amphotericin B
The Generic name of this drug
Treatment Summary
Amphotericin B is an antibiotic used to treat fungal infections caused by a variety of species including Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, and more. It is often effective against Candida albicans, although other species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are usually resistant to the drug. It is not effective against bacteria, rickettsiae, or viruses.
Fungizone
is the brand name
Amphotec Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Fungizone
Amphotericin B
1966
10
Approved as Treatment by the FDA
Amphotericin B, otherwise called Fungizone, is approved by the FDA for 28 uses like severe Fungal infection caused by Basidiobolus spp. and severe Fungal infection caused by Conidiobolus spp. .
severe Fungal infection caused by Basidiobolus spp.
severe Fungal infection caused by Conidiobolus spp.
severe Mucocutaneous leishmaniasis
severe Fungal infection caused by sporotrichosis spp.
severe North American blastomycosis
Histoplasmosis
Leishmaniasis, Visceral
Sporotrichosis
Mycoses
Cryptococcosis
Febrile Neutropenia
failed previous amphotericin B treatment
Used to treat failed previous amphotericin B treatment in combination with DL-dimyristoylphosphatidylcholine
severe Histoplasmosis
Visceral Leishmaniasis
severe Cryptococcosis
severe Systemic candidiasis
Mucocutaneous Leishmaniasis
Meningitis, Cryptococcal
Febrile Neutropenia
Leishmaniasis, Cutaneous
Gilchrist Disease
Coccidioidomycosis
Systemic candidiasis
Leishmaniasis, Mucocutaneous
Mycoses
Cerebral Cryptococcosis
HIV
Invasive Fungal Infections
Effectiveness
How Amphotec Affects Patients
Amphotericin B is an effective antifungal drug that can be used to treat a wide range of fungi, including Histoplasma capsulatum, Coccidioides immitis, Candida species, and Blastomyces dermatitidis, among others. It does not work on bacteria, rickettsiae, or viruses. The effectiveness of Amphotericin B on Candida albicans is usually good, but it is usually not as effective on other non-albicans species. Pseudallescheria boydii and Fusarium species are usually resistant to this drug.
How Amphotec works in the body
Amphotericin B is a drug that can kill or stop the growth of certain types of fungi. It works by binding to a part of the cell membrane, called ergosterol, in susceptible fungi. This binding creates a channel in the membrane, which changes how it interacts with other molecules. This change leads to the leakage of important components from inside the cell, eventually leading to the death of the cell.
When to interrupt dosage
The proposed dosage of Amphotec is contingent upon the diagnosed condition, for example Aspergillosis, serious Cryptococcosis and serious Mucocutaneous leishmaniasis. The dosage also varies as per the mode of administration referenced in the table beneath.
Condition
Dosage
Administration
Cerebral Cryptococcosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Tuberculosis, Osteoarticular
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Aspergillosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Gilchrist Disease
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Coccidioidomycosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Systemic candidiasis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Mycoses
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Aspergillosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Cystitis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Histoplasmosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Leishmaniasis, Cutaneous
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Mycoses
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Sporotrichosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
failed previous amphotericin B treatment
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Leishmaniasis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Cryptococcosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Histoplasmosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Coccidioidomycosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Cryptococcosis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Endophthalmitis
, 5.0 mg/mL, 5.0 mg/mg, 1.0 mg/mg, 50.0 mg, 100.0 mg, 30.0 mg/mL, 10.0 mg/mL
Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, , Injection, lipid complex - Intravenous, Injection, lipid complex, Powder, for suspension - Intravenous, Powder, for suspension, Suspension - Intravenous, Suspension, Cream - Topical, Lotion - Topical, Injection, Injection - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Topical
Warnings
There are 20 known major drug interactions with Amphotec.
Common Amphotec Drug Interactions
Drug Name
Risk Level
Description
Cyclosporine
Major
Amphotericin B may increase the nephrotoxic activities of Cyclosporine.
Neomycin
Major
The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Neomycin.
Tenofovir
Major
Amphotericin B may increase the nephrotoxic activities of Tenofovir.
Tenofovir alafenamide
Major
Amphotericin B may increase the nephrotoxic activities of Tenofovir alafenamide.
Tenofovir disoproxil
Major
Amphotericin B may increase the nephrotoxic activities of Tenofovir disoproxil.
Amphotec Toxicity & Overdose Risk
The toxic dose for rats is more than 5 grams per kilogram. If someone overdoes on amphotericin B, it could lead to cardiopulmonary arrest.
Amphotec Novel Uses: Which Conditions Have a Clinical Trial Featuring Amphotec?
At present, 10 active trials are assessing the utility of Amphotec in addressing Meningeal Fungal Infections, such as Histoplasmosis.
Condition
Clinical Trials
Trial Phases
Tuberculosis, Osteoarticular
0 Actively Recruiting
Coccidioidomycosis
0 Actively Recruiting
Cerebral Cryptococcosis
1 Actively Recruiting
Phase 2, Phase 3
Mycoses
0 Actively Recruiting
Aspergillosis
0 Actively Recruiting
Cryptococcosis
0 Actively Recruiting
Histoplasmosis
0 Actively Recruiting
Meningitis, Fungal
0 Actively Recruiting
Histoplasmosis
1 Actively Recruiting
Phase 3
Systemic candidiasis
3 Actively Recruiting
Phase 3, Phase 2
Febrile Neutropenia
3 Actively Recruiting
Phase 2, Not Applicable
Cryptococcosis
0 Actively Recruiting
talaromycosis
0 Actively Recruiting
Leishmaniasis, Cutaneous
0 Actively Recruiting
Invasive Fungal Infections
3 Actively Recruiting
Phase 3, Phase 2
Endophthalmitis
0 Actively Recruiting
Mycoses
0 Actively Recruiting
Leishmaniasis, Mucocutaneous
0 Actively Recruiting
Aspergillosis
0 Actively Recruiting
Gilchrist Disease
0 Actively Recruiting
Amphotec Reviews: What are patients saying about Amphotec?
4.3
Patient Review
11/30/2009
Amphotec for An Infection caused by the Fungus Zygomycetes
4
Patient Review
6/22/2008
Amphotec for Infection with Cryptococcus Fungus
Patient Q&A Section about amphotec
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.